Cavusoglu, Y. Et Al. 2008. Both levosimendan and dobutamine treatments result in significant reduction of NT-proBNP levels, but levosimendan has better and prolonged neurohormonal effects than dobutamine. INTERNATIONAL JOURNAL OF CARDIOLOGY , vol.127, no.3 .

Cavusoglu, Y., Tek, M., Birdane, A., Ata, N., Demirustu, C., Gorenek, B., ... Unalir, A.(2008). Both levosimendan and dobutamine treatments result in significant reduction of NT-proBNP levels, but levosimendan has better and prolonged neurohormonal effects than dobutamine. INTERNATIONAL JOURNAL OF CARDIOLOGY , vol.127, no.3.

Cavusoglu, Yuksel Et Al. "Both levosimendan and dobutamine treatments result in significant reduction of NT-proBNP levels, but levosimendan has better and prolonged neurohormonal effects than dobutamine," INTERNATIONAL JOURNAL OF CARDIOLOGY , vol.127, no.3, 2008

Cavusoglu, Yuksel Et Al. "Both levosimendan and dobutamine treatments result in significant reduction of NT-proBNP levels, but levosimendan has better and prolonged neurohormonal effects than dobutamine." INTERNATIONAL JOURNAL OF CARDIOLOGY , vol.127, no.3, 2008

Cavusoglu, Y. Et Al. (2008) . "Both levosimendan and dobutamine treatments result in significant reduction of NT-proBNP levels, but levosimendan has better and prolonged neurohormonal effects than dobutamine." INTERNATIONAL JOURNAL OF CARDIOLOGY , vol.127, no.3.

@article{article, author={Yuksel Cavusoglu Et Al. }, title={Both levosimendan and dobutamine treatments result in significant reduction of NT-proBNP levels, but levosimendan has better and prolonged neurohormonal effects than dobutamine}, journal={INTERNATIONAL JOURNAL OF CARDIOLOGY}, year=2008}